Surgalign Holdings, Inc.
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 16.75M | 20.57M | 20.18M | 20.62M | 20.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.75M | 20.57M | 20.18M | 20.62M | 20.61M |
| Cost of Revenue | 5.84M | 9.67M | 5.06M | 5.47M | 6.00M |
| Gross Profit | 10.91M | 10.90M | 15.12M | 15.16M | 14.61M |
| SG&A Expenses | 21.13M | 22.43M | 23.86M | 24.29M | 25.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -898.00K | -- | -- | -- |
| Total Operating Expenses | 29.87M | 34.53M | 32.78M | 33.84M | 35.76M |
| Operating Income | -13.12M | -13.96M | -12.60M | -13.21M | -15.16M |
| Income Before Tax | 4.28M | -40.45M | -9.80M | -5.60M | 189.00K |
| Income Tax Expenses | 133.00K | -1.34M | 38.00K | 92.00K | 162.00K |
| Earnings from Continuing Operations | 4.15M | -39.11M | -9.83M | -5.69M | 27.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.15M | -39.11M | -9.83M | -5.69M | 27.00K |
| EBIT | -13.12M | -13.96M | -12.60M | -13.21M | -15.16M |
| EBITDA | -12.62M | -13.51M | -12.05M | -12.60M | -14.60M |
| EPS Basic | 0.51 | -5.77 | -1.46 | -0.86 | 0.00 |
| Normalized Basic EPS | -0.60 | -0.58 | -1.34 | -0.51 | -0.66 |
| EPS Diluted | -0.03 | -5.77 | -1.46 | -0.86 | 0.00 |
| Normalized Diluted EPS | -0.36 | -0.58 | -1.34 | -0.51 | -0.64 |
| Average Basic Shares Outstanding | 8.07M | 6.78M | 6.74M | 6.64M | 5.73M |
| Average Diluted Shares Outstanding | 13.32M | 6.78M | 6.74M | 6.64M | 5.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |